In the RA group, the mean baseline DAS-28 CRP score of the patients who had polypharmacy at the 6th month was 4.66 ± 1.45 and the mean baseline score of those without polypharmacy at the 6th month was 4.93 ± 1.27. This evidence concerns the gene CRP and rheumatoid arthritis.